About
Contact & Profiles
A5082797850
Research Areas
- Viral-associated cancers and disorders
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
Memorial Sloan Kettering Cancer Center
2012
Limited data exist regarding the activity of bendamustine in Hodgkin lymphoma (HL). This phase II study evaluated efficacy relapsed and refractory HL.Patients with HL who were ineligible for autologous stem-cell transplantation (ASCT), or whom this treatment failed, received 120 mg/m(2) as a 30-minute infusion on days 1 2 every 28 growth factor support. The primary end point was overall response rate (ORR). A secondary referral to allogeneic (alloSCT) patients deemed eligible alloSCT at time...
10.1200/jco.2012.45.3308
article
EN
Journal of Clinical Oncology
2012-12-18
Coming Soon ...